Botox Approved for Third Application


The U.S. Food & Drug Administration (FDA) has approved the use of Botox for its third application: forehead lines. 

Although botulinum toxin injections are the leading esthetic procedure in the United States, Botox is currently the only product approved for three applications:

Three treatment cycles were conducted in clinical trials to determine Botox’s efficacy in the reduction of moderate to severe forehead lines. In two cycles, 61% and 46% of subjects, respectively, met the primary endpoint—day 30—compared to 0% and 1% in the placebo groups.

“Allergan recognizes that forehead lines are a top area of concern for patients. Our goal in pursuing a third indication for Botox Cosmetic … was based on our desire to study the patient selection, dosing and injection pattern to help provide optimal treatment outcomes,” said David Nicholson, chief research and development officer, Allergan.

More in MedSpa